Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Consent and privacy in pharmacogenetic testing.

J A Robertson1

  • 1School of Law, The University of Texas, Austin, Texas 78705, USA. jrobertson@mail.law.utexas.edu

Nature Genetics
|June 30, 2001
PubMed
Summary

Pharmacogenetic testing is needed for personalized medicine but may reveal sensitive DNA information. Ensuring patient privacy and informed consent is crucial for the safe clinical use of these drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Remarks on Iritis.

Edinburgh medical and surgical journal·2018
Same author

Remarks on Amaurosis, with Cases.

Edinburgh medical and surgical journal·2018
Same author

Sleep disturbance in patients taking opioid medication for chronic back pain.

Anaesthesia·2016
Same author

Renewal of Menstruation and Subsequent Pregnancy after Removal of Both Ovaries.

British medical journal·2010
Same author

Physicians rally against threat of a nuclear epidemic.

Canadian Medical Association journal·2010
Same author

Chalk river nuclear laboratories.

Canadian Medical Association journal·2010

Area of Science:

  • Pharmacogenomics
  • Clinical Pharmacology
  • Bioethics

Background:

  • The integration of pharmacogenetic drugs into clinical practice necessitates pre-prescription DNA testing for patients.
  • While pharmacogenetic tests are generally less risky than genetic tests for disease mutations, they can still uncover personal genetic information.

Purpose of the Study:

  • To highlight the importance of informed consent and privacy protections for pharmacogenetic testing.
  • To address potential adverse implications of incidental genetic findings from pharmacogenetic tests.

Main Methods:

  • Review of current clinical pharmacogenetic testing protocols.
  • Analysis of ethical considerations and privacy risks associated with genetic information.

Main Results:

  • Pharmacogenetic tests, though distinct from disease mutation tests, can yield sensitive personal genetic data.
  • Potential for misuse of revealed personal genetic information exists, impacting patient interests.

Conclusions:

  • Informed consent is a critical component for the ethical implementation of pharmacogenetic testing.
  • Robust privacy measures for pharmacogenetic test results are essential for patient trust and safety in clinical settings.
Keywords:
Genetics and ReproductionLegal Approach

Related Experiment Videos